The absence ofa chemical alteration called methylation on some stretches of DNA makes them especially prone to mutations, according to a paper published in PLoS Genetics in May1.
Studying DNA from human sperm, the researchers found that areas of the genome that lack methyl groups — modifications that can alter gene expression without changing the DNA sequence — are afflicted by mutations more often than highly methylated regions.
“Most of the genomic DNA was methylated, but a small percentage was not,” says lead investigator Aleksandar Milosavljevic, associate professor of molecular and human genetics at the Baylor College of Medicine in Houston, Texas. “What was very striking was that the part that was not methylated contained signs of high genomic instability.”
Scientists had already known that parts of the genome with low-copy repeats — short, repeated segments of genomic DNA — are particularly susceptible to CNVs. The new research shows that lack of methylation may be just as influential, and is the first to make the connection between methylation and structural mutations of the genome.
Comparing human, chimpanzee and other primate genomes, the researchers found that more than ten percent of changes to the human genome since we branched off from chimps six million years ago reside in the least methylated part of the genome. Even from person to person, they found more mutations overall, including CNVs and other types of mutations, in hypomethylated regions than elsewhere in the genome.
Several studies in the past few years have reported rare mutations linked to various neuropsychiatric conditions. Analyzing data from four recentstudies on CNVs — including 3,391 individuals with schizophrenia, 1,001 with bipolar disorder, 996 with autism spectrum disorders and 15,767 children with developmental delay — the researchers found that people with any of the four disorders have more CNVs than controls have in the hypomethylated regions of their DNA.What’s more, in each case, a number of known pathogenic CNVs appear in the hypomethylated regions.
“We’re not providing any answers for understanding disease etiology, but we’re opening up a new line of inquiry,” Milosavljevic says.
The decrease in methylation in people with autism found in the new study may explain why they have more CNVs than controls do.
Some children with autism have parents who have other neuropsychiatric disorders, such as bipolar disorder or obsessive-compulsive disorder, says Simon Gregory, associate professor of medical genetics at Duke University in Durham, North Carolina, who was not involved in the research. “If [the researchers] are able to identify a relationship between these methylation deserts and CNVs in these other disorders, we might be seeing a common mechanism.”
The new research begins to answer some longstanding questions, but it leaves many others up for debate. “Ten percent of the rearrangements occur in the methylation deserts, but 90 percent occur elsewhere,” Gregory says. “Perhaps it’s answering 10 percent of the problem, but that still leaves the other 90 percent.”
1: Li J. et al. PLoS Genet. Epub ahead of print (2012) PubMed